A platelet-inhibitor-drug trial in coronary-artery bypass operations: benefit of perioperative dipyridamole and aspirin therapy on early postoperative vein-graft patency.

To prevent occlusion of aortocoronary-artery-bypass grafts, we conducted a prospective, randomized-double-blind trial comparing dipyridamole (instituted two days before operation) plus aspirin (added seven hours after operation) with placebo in 407 patients. Vein-graft angiography was performed in 360 patients (88 per cent) within six months of operation (median, eight days). Within one month of operation, 3 per cent of vein-graft distal anastomoses (10 of 351) were occluded in the treated patients, and 10 per cent (38 of 362) in the placebo group; the proportion of patients with one or more distal anastomoses occluded was 8 per cent (10 of 130) in the treated group and 21 per cent (27 of 130) in th placebo group. This benefit in graft patency persisted in each of over 50 subgroups. Early postoperative bleeding was similar in the two groups. In this trial dipyridamole and aspirin were effective in preventing graft occlusion early after operation.

[1]  H. Baur,et al.  Effects of sulfinpyrazone on early graft closure after myocardial revascularization. , 1982, The American journal of cardiology.

[2]  S. Gates,et al.  The effect of antithrombotic therapy on patency rates of saphenous vein coronary artery bypass grafts. , 1982, The Journal of thoracic and cardiovascular surgery.

[3]  R. Bianco,et al.  Reduction of thrombosis in canine coronary bypass vein grafts with dipyridamole and aspirin. , 1981, The American journal of cardiology.

[4]  J. Mayer,et al.  Influence of aspirin and dipyridamole on patency of coronary artery bypass grafts. , 1981, The Annals of thoracic surgery.

[5]  V. Fuster,et al.  Platelet Survival and the Development of Coronary Artery Disease in the Young Adult: Effects of Cigarette Smoking, Strong Family History and Medical Therapy , 1981, Circulation.

[6]  J. Roth,et al.  Improved graft patency with antiplatelet drugs in patients treated for one year following coronary bypass surgery , 1981 .

[7]  R. Frye,et al.  Improvement of left ventricular exercise hemodynamic function after aorta-coronary artery bypass grafting. , 1981, The Journal of thoracic and cardiovascular surgery.

[8]  D. Hunt,et al.  Prospective angiographic assessment of factors affecting early patency of saphenous vein-coronary artery bypass grafts. , 1980, Australian and New Zealand journal of medicine.

[9]  M. Bourassa.  The Role of Bypass Surgery in Isolated Left Anterior Descending Artery Stenosis or Occlusion , 1980, Circulation.

[10]  R. Dinsmore,et al.  Late graft patency and symptom relief after aorta-coronary bypass. , 1980, The Journal of thoracic and cardiovascular surgery.

[11]  V. Fuster,et al.  Noninvasive Radioisotopic Technique for Detection of Platelet Deposition in Coronary Artery Bypass Grafts in Dogs and Its Reduction with Platelet Inhibitors , 1979, Circulation.

[12]  S. Rahimtoola,et al.  Failure of antiplatelet and anticoagulant therapy to improve patency of grafts after coronary-artery bypass: a controlled, randomized study. , 1979, The New England journal of medicine.

[13]  R. Hamby,et al.  Aortocoronary Saphenous Vein Bypass Grafts: Long-term Patency, Morphology and Blood Flow in Patients with Patent Grafts Early After Surgery , 1979, Circulation.

[14]  P. Steele,et al.  Platelet Suppressant Therapy in Patients with Prosthetic Cardiac Valves: Relationship of Clinical Effectiveness to Alteration of Platelet Survival Time , 1979, Circulation.

[15]  V. Fuster,et al.  Reduction of intimal thickening in canine coronary bypass vein grafts with dipyridamole and aspirin. , 1978, The American journal of cardiology.

[16]  E. Michelson,et al.  Aspirin- and coumadin-related bleeding after coronary- artery bypass graft surgery. , 1978, Annals of internal medicine.

[17]  A. Bove,et al.  Left Ventricular Function Following Coronary Bypass Surgery , 1978, Circulation.

[18]  S. Moncada,et al.  DIPYRIDAMOLE AND OTHER PHOSPHODIESTERASE INHIBITORS ACT AS ANTITHROMBOTIC AGENTS BY POTENTIATING ENDOGENOUS PROSTACYCLIN , 1978, The Lancet.

[19]  Hutchins Gm,et al.  Pathology of coronary artery bypass graft surgery. , 1978 .

[20]  J. Burton,et al.  Coronary Bypass Graft Fate: Angiographic Grading of 1400 Consecutive Grafts Early after Operation and of 1132 after One Year , 1978, Circulation.

[21]  W. Harris,et al.  Aspirin Prophylaxis of Venous Thromboembolism after Total Hip Replacement , 1977 .

[22]  E. Ritman,et al.  Videometric analysis of regional left ventricular function before and after aortocoronary artery bypass surgery: correlation of peak rate of myocardial wall thickening with late postoperative graft flows. , 1976, The Journal of clinical investigation.

[23]  C. W. Hartman,et al.  Aortocoronary bypass surgery: Correlation of angiographic symptomatic and functional improvement at 1 year. , 1976, The American journal of cardiology.

[24]  R. Frye,et al.  Pathologic changes in aortocoronary saphenous vein grafts. , 1974, The American journal of cardiology.

[25]  L. Harker,et al.  Platelet and fibrinogen consumption in man. , 1972, The New England journal of medicine.

[26]  J. Edwards,et al.  Pathologic Changes in Aortic‐Coronary Arterial Saphenous Vein Grafts , 1971, Circulation.

[27]  L. Harker,et al.  Studies of platelet and fibrinogen kinetics in patients with prosthetic heart valves. , 1970, The New England journal of medicine.